AP19

General Information


DRACP ID  DRACP04569

Peptide Name   AP19

Sequence  RLFRRVKKVAGKIAKRIWK

Sequence Length  19

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C110H193N37O20

Absent amino acids  CDEHMNPQSTY

Common amino acids  K

Mass  267522

Pl  13

Basic residues  9

Acidic residues  0

Hydrophobic residues  9

Net charge  9

Boman Index  -5472

Hydrophobicity  -58.95

Aliphatic Index  102.63

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  305.56

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 36151303

Title  Novel D-form of hybrid peptide (D-AP19) rapidly kills Acinetobacter baumannii while tolerating proteolytic enzymes

Doi Not available

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  20599

DRACP is developed by Dr.Zheng's team.